Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Francesco Dotta Anders G Holst Andrew Ahmann Ildiko Lingvay |
| Publication date | December 15, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |